Details for Patent: 8,580,781
Which drugs does patent 8,580,781 protect, and when does it expire?
Patent 8,580,781 protects TEPMETKO and is included in one NDA.
This patent has eighty patent family members in thirty-seven countries.
Summary for Patent: 8,580,781
| Title: | Pyridazinone derivatives |
| Abstract: | Compounds of the formula (I), in which R1, R2, R3, R4, R4′ have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumors. |
| Inventor(s): | Dieter Dorsch, Frank Stieber, Oliver Schadt, Andree Blaukat |
| Assignee: | Merck Patent GmbH |
| Application Number: | US12/668,535 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Process; Device; |
Drugs Protected by US Patent 8,580,781
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono Inc | TEPMETKO | tepotinib hydrochloride | TABLET;ORAL | 214096-001 | Feb 3, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,580,781
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 10 2007 032 507 | Jul 12, 2007 |
| PCT Information | |||
| PCT Filed | April 29, 2008 | PCT Application Number: | PCT/EP2008/003473 |
| PCT Publication Date: | January 15, 2009 | PCT Publication Number: | WO2009/006959 |
International Family Members for US Patent 8,580,781
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2164843 | ⤷ Start Trial | C02164843/01 | Switzerland | ⤷ Start Trial |
| European Patent Office | 2164843 | ⤷ Start Trial | 301176 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2164843 | ⤷ Start Trial | PA2022009 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2164843 | ⤷ Start Trial | 2022C/519 | Belgium | ⤷ Start Trial |
| European Patent Office | 2164843 | ⤷ Start Trial | LUC00264 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 2164843 | ⤷ Start Trial | CA 2022 00021 | Denmark | ⤷ Start Trial |
| European Patent Office | 2164843 | ⤷ Start Trial | 122022000047 | Germany | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
